A Study to Evaluate the Safety and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections
Clinical trial NCT05544916 · COMPLETED
Trial details
- NCT number
- NCT05544916
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-05
- Primary completion
- 2023-02-01
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.